A new pharmaceutical company, Revance Therapies, has been testing and researching a new substance that may compete against major products like Botox Cosmetic, Dysport, and Xeomin. The major and possible market changing different is the the new product is delivered via topical application, much like a cream. Early studies have demonstrated equal potency, less risk, and longer lasting results. The introduction of this product may prove a titan in the aesthetic medicine field.

Read more about this product here. 

AuthorOscar Bueno